BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wahid HH, Chin PY, Sharkey DJ, Diener KR, Hutchinson MR, Rice KC, Moldenhauer LM, Robertson SA. Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice. Am J Pathol 2020;190:1030-45. [PMID: 32084361 DOI: 10.1016/j.ajpath.2020.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chan HY, Moldenhauer LM, Groome HM, Schjenken JE, Robertson SA. Toll-like receptor-4 null mutation causes fetal loss and fetal growth restriction associated with impaired maternal immune tolerance in mice. Sci Rep 2021;11:16569. [PMID: 34400677 DOI: 10.1038/s41598-021-95213-1] [Reference Citation Analysis]
2 Robertson SA, Hutchinson MR, Rice KC, Chin PY, Moldenhauer LM, Stark MJ, Olson DM, Keelan JA. Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury. Clin Transl Immunology 2020;9:e1121. [PMID: 32313651 DOI: 10.1002/cti2.1121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zierden HC, Shapiro RL, DeLong K, Carter DM, Ensign LM. Next generation strategies for preventing preterm birth. Adv Drug Deliv Rev 2021;174:190-209. [PMID: 33895215 DOI: 10.1016/j.addr.2021.04.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gomez-Lopez N, Garcia-Flores V, Chin PY, Groome HM, Bijland MT, Diener KR, Romero R, Robertson SA. Macrophages exert homeostatic actions in pregnancy to protect against preterm birth and fetal inflammatory injury. JCI Insight 2021;6:e146089. [PMID: 34622802 DOI: 10.1172/jci.insight.146089] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]